SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises


Vaccine manufacturers empowered to release up to 50% of their supply to State Govts. and in the open market at a pre-declared price

Government of India announces a Liberalised and Accelerated Phase 3 Strategy of Covid-19 Vaccination from May 1, 2021

Apr 19, 2021

By : Team ABLE

DBT to fund Bharat Biotech to augment Covaxin capacity

Bharat Biotech, Haffkine Biopharma, Indian Immunologicals, and BIBCOL to enhance production of indigenous vaccine Covaxin. India aims to produce 10 crore (100 million) doses by September 2021.

Apr 16, 2021

By : Team ABLE

Serum Institute appeals to President Biden for Covid vaccine raw materials

In an unprecedented action, Serum Institute of India CEO Mr Adar Poonawalla has appealed directly to US President Mr Joe Biden to lift restrictions on exports of some key raw materials from the US that Serum needs to make the Covishield vaccine to prevent Covid infection.

Apr 16, 2021

By : Narayanan Suresh

G S Krishnan takes over as new ABLE President

“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.

Apr 01, 2021

By : Team ABLE

Bharat Biotech, Biovet, Sapigen Biologix Signs Collaborative Research Agreemente with CSIR-IICT

Bharat Biotech International, Biovet, and Sapigen Biologix have signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT) today, to collaborate on the development of novel platform technologies for Bio Therapeutics and vaccines to support the indigenous, affordable health care solutions for humans and animals

Mar 29, 2021

By : Team ABLE